Juvenile generalized pustular psoriasis is a chronic recalcitrant disease: an analysis of 27 patients seen in a tertiary hospital in Johor, Malaysia

Int J Dermatol. 2017 Apr;56(4):392-399. doi: 10.1111/ijd.13489. Epub 2017 Feb 14.

Abstract

Background: Limited information exists regarding juvenile generalized pustular psoriasis (GPP). We aim to determine the clinical profile and outcome of Malaysians with juvenile GPP.

Methods: Review of hospital case notes on patients with juvenile GPP.

Results: Twenty-seven patients with juvenile GPP were identified. Female to male ratio was 1.4:1. The median age at onset of GPP was 6.5 years. Ten patients had prior psoriasis with a median pre-pustular duration of 2.7 years. Onset of GPP was earlier in patients without prior psoriasis (5.1 years vs. 12.0 years, P = 0.002). Precipitating factors identified included stress, upper respiratory tract infection, systemic steroid use, vaccination, and pregnancy. A positive family history of psoriasis and GPP was present in six and one patient(s), respectively. Twenty-one patients had acute, five annular, and one localized variant of GPP. Arthritis was present in 22.2%. Fever, leukocytosis, and transaminitis were mainly seen in patients with acute GPP at 80.9, 72.2, and 11.1%, respectively. Among 20 patients screened, eight carry IL36RN variants and one has CARD14 mutation. IL36RN-positive patients have more severe disease characterized by early onset, low prevalence of prior plaque psoriasis, high prevalence of systemic inflammation, and need for continuous long-term systemic therapy. Acitretin and cyclosporine were effective in aborting acute GPP in 100% of 16 and 66.7% of six patients treated, respectively. However, relapses were common. Only three of the 17 patients whose initial acute GPP was controlled with systemic agents were successfully weaned off treatment.

Conclusions: Juvenile GPP is a chronic recalcitrant disease. IL36RN-positive patients have more severe disease.

Publication types

  • Case Reports

MeSH terms

  • Acitretin / therapeutic use
  • Acute Disease
  • Adolescent
  • Adult
  • Age of Onset
  • CARD Signaling Adaptor Proteins / genetics
  • Child
  • Child, Preschool
  • Chronic Disease
  • Cyclosporine / therapeutic use
  • Dermatologic Agents / therapeutic use
  • Female
  • Guanylate Cyclase / genetics
  • Humans
  • Interleukins / genetics
  • Keratolytic Agents / therapeutic use
  • Malaysia / epidemiology
  • Male
  • Membrane Proteins / genetics
  • Pregnancy
  • Pregnancy Complications / etiology*
  • Psoriasis / drug therapy*
  • Psoriasis / etiology*
  • Psoriasis / pathology
  • Respiratory Tract Infections / complications
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index
  • Steroids / adverse effects
  • Stress, Psychological / complications
  • Tertiary Care Centers
  • Vaccination / adverse effects
  • Young Adult

Substances

  • CARD Signaling Adaptor Proteins
  • Dermatologic Agents
  • IL36RN protein, human
  • Interleukins
  • Keratolytic Agents
  • Membrane Proteins
  • Steroids
  • Cyclosporine
  • CARD14 protein, human
  • Guanylate Cyclase
  • Acitretin